| Dr Paul Chi Tung, CRNA | |
|
20333 W 151st St, Olathe, KS 66061-5350 | |
| (913) 791-4208 | |
| (913) 782-2381 |
| Full Name | Dr Paul Chi Tung |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 6 Years |
| Location | 20333 W 151st St, Olathe, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407438385 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 000000 (Kansas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Olathe Medical Center | Olathe, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Kansas University Physicians, Inc. | 8921911587 | 1456 |
News Archive
A previously unknown synthetic "designer" steroid has been identified as tetrahydrogestrinone (THG). Researchers working out of the UCLA Olympic Analytical Laboratory in Los Angeles synthesized and characterized the "New Chemical Entity", and proceeded to develop a rapid and accurate urine detection test for it.
The ability to detect potentially fatal illness early on in the course of the disease would enable a swift prioritization of these high-risk individuals for treatment. A new preprint on the medRxiv* server presents an array of biomarkers that may help achieve this laudable goal.
Wolters Kluwer Health and the American Physical Therapy Association (APTA) today announced an agreement to publish the Journal of Acute Care Physical Therapy, Official Journal of the Acute Care Section of the APTA, effective with the September 2013 issue.
Array BioPharma Inc. announced today that a $10 million clinical research milestone was achieved in its collaboration with Celgene Corporation. Celgene and Array entered into this research collaboration in September 2007. Array anticipates initiating a Phase 1 dose escalation trial in cancer patients with ARRY-382, a small molecule cFMS inhibitor, during the first quarter of 2011.
› Verified 2 days ago
| Entity Name | Kansas University Physicians, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1003858333 PECOS PAC ID: 8921911587 Enrollment ID: O20040401000328 |
News Archive
A previously unknown synthetic "designer" steroid has been identified as tetrahydrogestrinone (THG). Researchers working out of the UCLA Olympic Analytical Laboratory in Los Angeles synthesized and characterized the "New Chemical Entity", and proceeded to develop a rapid and accurate urine detection test for it.
The ability to detect potentially fatal illness early on in the course of the disease would enable a swift prioritization of these high-risk individuals for treatment. A new preprint on the medRxiv* server presents an array of biomarkers that may help achieve this laudable goal.
Wolters Kluwer Health and the American Physical Therapy Association (APTA) today announced an agreement to publish the Journal of Acute Care Physical Therapy, Official Journal of the Acute Care Section of the APTA, effective with the September 2013 issue.
Array BioPharma Inc. announced today that a $10 million clinical research milestone was achieved in its collaboration with Celgene Corporation. Celgene and Array entered into this research collaboration in September 2007. Array anticipates initiating a Phase 1 dose escalation trial in cancer patients with ARRY-382, a small molecule cFMS inhibitor, during the first quarter of 2011.
› Verified 2 days ago
| Entity Name | Johnson County Anesthesiologists, Chartered |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811940877 PECOS PAC ID: 8123923653 Enrollment ID: O20040506001122 |
News Archive
A previously unknown synthetic "designer" steroid has been identified as tetrahydrogestrinone (THG). Researchers working out of the UCLA Olympic Analytical Laboratory in Los Angeles synthesized and characterized the "New Chemical Entity", and proceeded to develop a rapid and accurate urine detection test for it.
The ability to detect potentially fatal illness early on in the course of the disease would enable a swift prioritization of these high-risk individuals for treatment. A new preprint on the medRxiv* server presents an array of biomarkers that may help achieve this laudable goal.
Wolters Kluwer Health and the American Physical Therapy Association (APTA) today announced an agreement to publish the Journal of Acute Care Physical Therapy, Official Journal of the Acute Care Section of the APTA, effective with the September 2013 issue.
Array BioPharma Inc. announced today that a $10 million clinical research milestone was achieved in its collaboration with Celgene Corporation. Celgene and Array entered into this research collaboration in September 2007. Array anticipates initiating a Phase 1 dose escalation trial in cancer patients with ARRY-382, a small molecule cFMS inhibitor, during the first quarter of 2011.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Chi Tung, CRNA Po Box 75443, Chicago, IL 60675-5443 Ph: (717) 263-5562 | Dr Paul Chi Tung, CRNA 20333 W 151st St, Olathe, KS 66061-5350 Ph: (913) 791-4208 |
News Archive
A previously unknown synthetic "designer" steroid has been identified as tetrahydrogestrinone (THG). Researchers working out of the UCLA Olympic Analytical Laboratory in Los Angeles synthesized and characterized the "New Chemical Entity", and proceeded to develop a rapid and accurate urine detection test for it.
The ability to detect potentially fatal illness early on in the course of the disease would enable a swift prioritization of these high-risk individuals for treatment. A new preprint on the medRxiv* server presents an array of biomarkers that may help achieve this laudable goal.
Wolters Kluwer Health and the American Physical Therapy Association (APTA) today announced an agreement to publish the Journal of Acute Care Physical Therapy, Official Journal of the Acute Care Section of the APTA, effective with the September 2013 issue.
Array BioPharma Inc. announced today that a $10 million clinical research milestone was achieved in its collaboration with Celgene Corporation. Celgene and Array entered into this research collaboration in September 2007. Array anticipates initiating a Phase 1 dose escalation trial in cancer patients with ARRY-382, a small molecule cFMS inhibitor, during the first quarter of 2011.
› Verified 2 days ago
Mary W Minden, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4340 | |
Deborah Marie Pelch, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, Suite 306, Olathe, KS 66061 Phone: 913-782-2292 Fax: 913-782-2381 | |
Mrs. Cindy J Goe, CRNA MA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 14619 S Lucille St, Olathe, KS 66062 Phone: 913-681-9716 | |
Jan L. Coons, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 20375 W 151st St, Suite 306, Olathe, KS 66061 Phone: 913-785-2292 Fax: 913-782-2381 | |
Ms. Michelle Salazar, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4200 | |
Timothy J Flynn, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 20375 W 151st St, Suite 306, Olathe, KS 66061 Phone: 913-782-2292 Fax: 913-782-2381 |